Click here to join

Investors & Media

What's new.

Press releases

Press releases.

Immutep Advances IMP761 Manufacturing

December 16th 2021
press releases

Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003

December 2nd 2021
press releases

Results of Annual General Meeting

November 26th 2021
press releases

Investor updates

Investor updates.

Investor Update - April 2021

April 14th 2021
investor updates

Investor Update - August 2020

August 17th 2020
investor updates

Investor Update - November 2019

November 22nd 2019
investor updates

Analyst reports

Analyst reports.

Jefferies - Turning Cold Cancers Hot – Initiating at Buy - TP to $A1 (ASX: IMM) (Analyst: Dr Dave Stanton)

For a copy of this Analyst report please contact your Jefferies advisor.

December 1st 2021
analyst reports

Taylor Collison - AIPAC disappoints but TACTI-003 adding value - Increasing TP to $A1.36 (from $A1.19) (ASX: IMM) (Analyst: Dr Dennis Hulme)

For a copy of this Analyst report please contact your Taylor Collison advisor.

November 23rd 2021
analyst reports

goetzpartners securities -Data highlights efti efficacy and potential central role in cancer therapy - Reiterate OUTPERFORM and TP of AUD 1.350

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

November 22nd 2021
analyst reports